Zaeske Adam H. 4
4 · Harmony Biosciences Holdings, Inc. · Filed Apr 16, 2025
Insider Transaction Report
Form 4
Zaeske Adam H.
CHIEF COMMERCIAL OFFICER
Transactions
- Award
Stock Option
2025-04-07+100,000→ 100,000 totalExercise: $28.40Exp: 2035-04-07→ Common Stock (100,000 underlying) - Award
Restricted Stock Units
2025-04-07+30,000→ 30,000 total→ Common Stock (30,000 underlying)
Footnotes (2)
- [F1]The stock option vests with respect to 25% of the underlying shares on April 7, 2026, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date.
- [F2]The restricted stock units shall vest in four equal annual installments beginning on April 7, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.